Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY INC. ANNOUNCES EXCLUSIVE STRATEGIC MARKETING PARTNERSHIP WITH MIXED MARTIAL ARTS GROUP LIMITED

The Precision Peptide Company Inc. has entered into an exclusive strategic marketing agreement dated May 8, 2026, with Mixed Martial Arts Group Ltd., a company based in New South Wales, Australia.

Under the strategic marketing agreement, the parties have entered into an exclusive partnership for the purposes of marketing and selling the company's peptide products to MMA's subscriber base. MMA operates one of the world's largest digitally connected combat sports ecosystems, with over five million social media followers, with approximately 530,000 user profiles, more than 75,000 active students and over 800 verified gyms globally, and will market the company's products to all individuals and entities subscribed to MMA's platform as of the effective date and throughout the term of the strategic marketing agreement.

Pursuant to the strategic marketing agreement, the company will pay MMA a share of net revenue derived exclusively from MMA-sourced sales. During the first 12 months following the effective date, net revenue from MMA-sourced sales will be split equally between the parties on a 50-per-cent/50-per-cent basis. Commencing in the 13th month following the effective date and for the rest of the term, net revenue from MMA-sourced sales will be distributed 75 per cent to the company and 25 per cent to MMA.

The strategic marketing agreement commences on May 8, 2026, and continues until terminated, with either party having the right to terminate for any reason upon no fewer than 30 days prior written notice. For a period of 12 months following termination or expiration of the strategic marketing agreement, the company will continue to account for and pay MMA's applicable profit share on sales to customers referred by MMA during the term.

All peptide products sold under the strategic marketing agreement will be manufactured in the United States, and will comply with all applicable U.S. regulatory requirements and standards, including those set by the U.S. Food and Drug Administration and any other applicable regulatory authority.

About The Precision Peptide Company Inc.

Precision Peptide is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

We seek Safe Harbor.